about
Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria dataQuantifying the pharmacology of antimalarial drug combination therapy.Local constraints to access appropriate malaria treatment in the context of parasite resistance in Cambodia: a qualitative study.Sugar nucleotide quantification by liquid chromatography tandem mass spectrometry reveals a distinct profile in Plasmodium falciparum sexual stage parasites.What's wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?Toward a Metagenomic Understanding on the Bacterial Composition and Resistome in Hong Kong Banknotes.K13-propeller Alleles, Mdr1 Polymorphism, and Drug Effectiveness at Day 3 after Artemether-lumefantrine Treatment for Plasmodium falciparum Malaria in Colombia, 2014-2015.Plasmodium falciparum specific helicase 3 is nucleocytoplasmic protein and unwinds DNA duplex in 3' to 5' direction.Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.High-Content Screening of MMV Pathogen Box for Plasmodium falciparum Digestive Vacuole Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum.Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance.Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials.Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association with Artemisinin Resistance.A Novel Single-Nucleotide Polymorphism Loop Mediated Isothermal Amplification Assay for Detection of Artemisinin-Resistant Plasmodium falciparum Malaria.Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016.Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile.Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast AsiaFitness Costs and the Rapid Spread of -C580Y Substitutions Conferring Artemisinin ResistanceLongitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites
P2860
Q28818002-5215FBA3-C688-4FFA-A67A-BC69A635EC1CQ37283299-767D1186-FB18-4DD1-8FB1-5E355693789BQ37650900-5159E2E2-1C51-4A9C-B740-014AB5F967A1Q37684503-568F44D2-111B-4AF2-8A89-43A18FCE2A52Q38975846-D0B10FA8-38E1-45A2-A883-3742BFBD9EE1Q40234591-AEF89C1E-2D25-4504-916B-A4FF11B0B22EQ41911890-C6A60963-B16E-4602-A2B6-0A1CED4B5DBCQ42377173-1EAC6DE5-0131-4150-911B-1CD3F4D75B53Q44169831-BF48CA6B-AED7-464A-9903-AD38DA7A5814Q47162062-E39DD855-43CA-4333-9627-39E274D18DDFQ47193275-CD97D8C7-635E-4B89-BF78-622CA6D782BBQ47666846-6B84458E-366B-4E5F-A3FD-587D160E1943Q48003582-5BAA2AC7-F395-403A-82D8-D69D77E2DF5CQ48016217-416744C8-0F33-44E2-8996-E064873CAFBEQ48016385-E5484594-1B63-497A-9CF7-62853957E5EDQ48022305-8469C4B8-3D1F-4631-A0A8-947037083FF0Q48023117-237849FF-0806-4035-AD40-2037C77FD1E5Q48095893-5AD9A3EC-CA72-4682-94D6-39E5A9C803D7Q52585854-D1970054-4F40-4DDB-B729-003D2DA46BF3Q53690278-FDFCBBB7-F376-42D2-ADCE-4BA8E17559E0Q53701065-68D37115-3043-4F19-9284-2A96FDC91E26Q55305165-54765051-1D86-4CB4-A594-E0211A1AB337Q55380572-1139A8CE-8D9A-441C-9A32-629E7CF5681CQ55491440-350D0F06-8A93-4103-82EF-5934CFE610CAQ56339766-1E5C3B77-1E13-4BAD-B347-972D8B6BF257Q56340109-232E4227-FAA8-4666-A38B-6911E60418CDQ56351183-669DB697-8DFC-4D7D-A943-CAF762EAE525
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Artemisinin-Resistant Plasmodium falciparum Malaria.
@en
Artemisinin-Resistant Plasmodium falciparum Malaria.
@nl
type
label
Artemisinin-Resistant Plasmodium falciparum Malaria.
@en
Artemisinin-Resistant Plasmodium falciparum Malaria.
@nl
prefLabel
Artemisinin-Resistant Plasmodium falciparum Malaria.
@en
Artemisinin-Resistant Plasmodium falciparum Malaria.
@nl
P2860
P921
P1476
Artemisinin-Resistant Plasmodium falciparum Malaria.
@en
P2860
P356
10.1128/MICROBIOLSPEC.EI10-0013-2016
P577
2016-06-01T00:00:00Z